Cytogen Corporation

Location:

650 College Road East Suite 3100PrincetonNew Jersey08540United States View Map

Revenue:

$15.2 Million

Employees:

76

SIC Codes:

2834

NAICS Codes:

325412

Phone:

(609) 750-8200

Fax:

(609) 452-2476
More

Description:

Cytogen is a specialty pharmaceutical company dedicated to advancing the treatment and care of patients by building, developing, and commercializing a portfolio of oncology products. The company's specialized sales force currently markets two therapeutic products and one diagnostic product to the U.S. oncology market. CAPHOSOL(R) is an advanced electrolyte solution for the treatment of oral mucositis and dry mouth that is approved in the U.S. as a prescription medical device. QUADRAMET(R) (samarium Sm-153 lexidronam injection) is approved for the treatment of pain in patients whose cancer has spread to the bone. PROSTASCINT(R) (capromab pendetide) is a PSMA-targeting monoclonal antibody-based agent to image the extent and spread of prostate cancer. The company also currently has U.S. commercial rights to SOLTAMOX(TM) (tamoxifen citrate), a liquid hormonal therapy approved in the U.S. for the treatment of breast cancer in adjuvant and metastatic settings. Cytogen's product-focused strategy centers on attaining sustainable growth through clinical, commercial, and strategic initiatives.

Read More

Competitors

Browse ZoomInfo’s Directories